Trends in pediatric ICU admissions and mortality in children with HIV/AIDS Pre & Post-HAART (highly active anti-retroviral therapy)

被引：0
|
作者：
Mathur, Mudit [1 ]
Shah, Vikas [2 ]
Piecuch, Steven [2 ]
Goldman, Gilbert M. [3 ]
Desai, Ninad [4 ]
机构：
[1] Loma Linda Univ, Childrens Hosp, Loma Linda, CA 92350 USA
[2] Kings Cty Hosp Ctr, Brooklyn, NY USA
[3] Roosevelt Hosp, New York, NY USA
[4] Kings Cty Hosp Ctr, Pediat HIV Serv, Brooklyn, NY USA
来源：
CRITICAL CARE MEDICINE | 2007年 / 35卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
894
引用
收藏
页码：A248 / A248
页数：1
相关论文
共 50 条
  • [21] Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients
    Amirayan-Chevillard, N
    Tissot-Dupont, H
    Capo, C
    Brunet, C
    Dignat-George, F
    Obadia, Y
    Gallais, H
    Mege, JL
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (01): : 107 - 112
  • [22] Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients
    de Olalla, PG
    Martínez-González, MA
    Caylà, JA
    Jansà, JM
    Iglesias, B
    Guerrero, R
    Marco, A
    Gatell, JM
    Ocaña, I
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2002, 6 (12) : 1051 - 1057
  • [23] Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era: comment
    Kapoor, Kapil G.
    Gibran, Syed K.
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 (09): : 918 - 919
  • [24] Ophthalmic manifestations and risk factors for mortality of HIV patients in the post-highly active anti-retroviral therapy era: response
    Thomas, Ravi
    Mengersen, Kerrie
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 (09): : 919 - 921
  • [25] Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality
    Stebbing, J.
    Bower, M.
    Mandalia, S.
    Nelson, M.
    Gazzard, B.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 145 (02): : 271 - 276
  • [26] Improvement of onychomycosis without antifungal therapy after initiation of highly active anti-retroviral therapy (HAART) in an HIV-infected patient
    Tachikawa, N
    Yasuoka, A
    Oka, S
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 1999, 52 (06) : 245 - 246
  • [27] Malignancies associated with pediatric HIV infection: Long term survivors on highly active anti retroviral therapy (HAART)
    Desai, N
    Rao, SP
    Miller, ST
    Handelsman, E
    Fikrig, S
    Mendez, H
    JOURNAL OF INVESTIGATIVE MEDICINE, 1998, 46 (01) : 172A - 172A
  • [28] Idiopathic Esophageal Ulcers in AIDS Completely Healed With Highly Active Anti-Retroviral Therapy
    Bromberg, David J.
    Gill, Jeffrey A.
    ACG CASE REPORTS JOURNAL, 2015, 2 (03): : 127 - 128
  • [29] Predictors of immunologic failure in treatment naive HIV infected patients who start highly active anti-retroviral therapy (HAART)
    Tesema, A.
    Kumie, A.
    Showa-Amare, A.
    G-Yohannes, A.
    Gabrekidan, T.
    HIV MEDICINE, 2012, 13 : 31 - 31
  • [30] Preservation of genital tract T cell immunity in HIV-infected women on highly active anti-retroviral therapy (HAART)
    Mkhize, N. N.
    Gumbi, P. P.
    Denny, L.
    Passmore, J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A84 - A85
12345